Last year Oxford Nanopore launched its first product, a portable low-cost device the size of a chocolate bar that analyses DNA. The device helps scientists identify bacteria and viruses, track disease outbreaks and study the DNA of humans, animals and plants. It has already been sold in more than 34 countries and was used in Guinea during the recent ebola outbreak. In July the device was taken to the International Space Station, where it could be used for onboard biological experiments, including the monitoring of astronaut health. The firm was spun-out of the University of Oxford in 2005, and has secured £251m in funding, valuing it at £930m in February. Under co-founder and chief executive Gordon Sanghera, 55, revenue was £746,000 last year, which represents seven month of sales.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.